Table 3.
RQ of lncRNA-RP11-513I15.6
|
RQ of miR-1262
|
RQ of miR-1298
|
||||
Liver
|
Serum
|
Liver
|
Serum
|
Liver
|
Serum
|
|
Naïve | 2.33 ± 0.31 | 1.86 ± 0.41 | 0.38 ± 0.09 | 0.26 ± 0.34 | 0.77 ± 0.26 | 0.1 ± 0.04 |
Week 10 | ||||||
DEN | 1.31 ± 0.36d | 0.99 ± 0.15d | 1.63 ± 0.28d | 1.40 ± 0.13d | 1.55 ± 0.37d | 1.08 ± 0.11d |
DEN + 100 AAF | 1.03 ± 0.2d | 0.63 ± 0.13d,e | 2.26 ± 0.54d | 2.23 ± 0.19d | 1.85 ± 0.12d | 1.48 ± 0.56d |
DEN + 200 AAF | 0.58 ± 0.12a,d,e | 0.44 ± 0.05d,e | 2.52 ± 0.44d,e | 2.81 ± 0.49d,e | 2.46 ± 0.37d,e | 1.82 ± 0.47b,c,d,e |
DEN + 300 AAF | 0.47 ± 0.037b,d,e | 0.39 ± 0.005d,e | 3.9 ± 0.36d,e | 3.59 ± 1.10b,d,e | 2.88 ± 0.11d,e | 3.30 ± 0.18d,e |
Week 16 | ||||||
DEN | 0.76 ± 0.1d | 0.52 ± 0.13d | 3.12 ± 0.62d | 2.15 ± 0.08d | 2.52 ± 0.56d | 2.23 ± 0.26d |
DEN + 100 AAF | 0.46 ± 0.04d,f | 0.22 ± 0.04d | 4.48 ± 0.63d,f | 4.08 ± 0.32d | 3.92 ± 0.61d,f | 4.56 ± 0.61d,f |
DEN + 200 AAF | 0.26 ± 0.07d,f | 0.14 ± 0.07d,f | 5.71 ± 0.76a,d,f | 7.38 ± 2.24d,f | 4.58 ± 0.56d,f | 5.78 ± 1.72d,f |
DEN + 300 AAF | 0.14 ± 0.04b,d,f | 0.12 ± 0.06d,f | 6.45 ± 1.04b,d,f | 9.78 ± 4.32b,d,f | 5.89 ± 1.27d,f | 7.38 ± 2.05b,d,f |
Values are mean ± SD; number of animals = 6 rats/each group.
P < 0.05 when DEN + 200 acetylaminofluorene (AAF) is compared to the DEN + 100 AAF.
P < 0.05 when DEN + 300 AAF is compared to the DEN + 100 AAF.
P < 0.05 when DEN + 300 AAF is compared to the DEN + 200 AAF.
P < 0.05 compared to the naïve group.
P < 0.05 compared to the diethylnitrosamine (DEN) group at week 10 group.
P < 0.05 compared to the DEN at week 16 group. One-way ANOVA followed by Tukey's multiple comparison test. DEN: Diethylnitrosamine; 2-AAF: 2-Acetylaminofluorene; RQ: Relative quantification; lncRNA: Long-noncoding RNA; miR: MicroRNA.